The effects of the growth factor-antagonist, trapidil, on remyelination in the CNS

Neuropathology and Applied Neurobiology

Volumn 23, Issue 1, 1997, Pages 50-58

  McKay, J S ^a   Blakemore, W F ^a   Franklin, R J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

CNS; Demyelination; Growth factor; Lysolecithin; PDGF; Remyelination; Trapidil

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; PLATELET DERIVED GROWTH FACTOR; SODIUM CHLORIDE; TRAPIDIL;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MYELIN SHEATH; NERVE FIBER; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; REMYELINIZATION; SPINAL CORD;

EID: 0031044098     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1997.tb01185.x     Document Type: Article

References (49)

1. Armstrong RC, Harvath L, Dubois-Dalcq M. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J Neurosci Res 1990; 27: 400-7
2. Barres BA, Hart IK, Coles SR et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992; 70: 31-46
3. Barres BA, Jacobsen MD, Schmid R, Sendtner M, Raff MC. Does oligodendrocyte survival depend on axons? Curr Biol 1993; 3: 489-97
4. Barres BA, Raff MC, Gaese F, Bartke I, Dechant G, Barde Y.-A. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 1994; 367: 371-5
5. Barres BA, Schmid R, Sendnter M, Raff MC. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993; 118: 283-95
6. Blakemore WF. Invasion of Schwann cells into the spinal cord of the rat following local injections of lysolecithin. Neuropath Appl Neurobiol 1978; 4: 47-59
7. Blakemore WF. Observations on myelination and remyelination in the central nervous system. In Development in the Nervous System, Eds Garrod and Feldman. Cambridge: Cambridge University Press, 1981: 289-307
8. Carroll WM, Jennings AR. Early recruitment of oligodendrocyte precursors in CNS demyelination. Brain 1994; 117: 563-78
9. Dubois-Dalcq M, Armstrong R. The cellular and molecular events of central nervous system remyelination. BioEssays 1990; 12: 569-76
10. Eddleston M, Mucke L. Molecular profile of reactive astrocytes: implications for their role in neurologic disease. Neuroscience 1993; 54: 15-36
11. Engel U, Wolswijk G. Oligodendrocyte-type-2 astrocyte (O-2 A) progenitor cells derived from adult rat spinal cord: in vitro characteristics and response to PDGF, bFGF and NT-3. Glia 1996; 16: 16-26
12. Franklin RJM, Crang AJ, Blakemore WF. Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord. J Neurocytol 1991; 20: 420-30
13. Franklin RJM, Gilson JM. Remyelinalion in the CNS of the hypothyroid rat. NeuroReport 1996; 7: 1526-30
14. Fressinaud C, Vallat JM. Basic fibroblast growth factor improves recovery after chemically induced breakdown of myelin-like membranes in pure oligodendrocyte cultures. J Neurosci Res 1994; 38: 202-13
15. Fressinaud C, Vallat JM, Labourdette G. Basic fibroblast growth factor down-regulates myelin basic protein gene expression and alters myelin compaction of mature oligodendrocytes in vitro. J Neurosci Res 1995; 40: 285-93
16. Fressinaud C, Vallat JM, Pouplard-Barthelaix A. Platelet-derived growth factor partly prevents chemically induced oligodendrocyte death and improves myelin-like membranes repair in vitro. Glia 1996; 16: 40-50
17. Gard AL, Pfeiffer SE. Glial cell mitogens bFGF and PDGF differentially regulate development of O4+GalC-oligodendrocyte progenitors. Dev Biol 1995; 159: 618-30
18. Gesualdo L, Dipaolo S, Ranieri E, Schena FP, Brunaccini A. Trapidil inhibits human mesangial cell-proliferation-effect on PDGF beta-receptor binding and expression. Kidney Int 1994; 46: 1002-9
19. Gilson J, Blakemore WF. Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropath Appl Neurobiol 1993; 19: 173-81
20. Godfraind C, Friedrich VL, Holmes KV, Dubois-Dalcq M. In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice. J Cell Biol 1989; 109: 2405-16
21. Graça DL, Blakemore WF. Delayed remyelination in rat spinal cord following ethidium bromide injection. Neuropathol Appl Neurobiol 1986; 12: 593-605
22. Grinspan JB, Franceschini B. Platelet-derived growth factor is a survival factor for PSA-NCAM+oligodendrocyte preprogenitor cells. J Neurosci Res 1995; 41: 540-51
23. Grinspan JB, Stern JL, Pustilnik SM, Pleasure D. Cerebral while matter contains PDGF-responsive precursors to O2 A cells. J Neurosci 1990; 10: 1866-73
24. Grinspan JB, Wrabetz L, Kamholz J. Oligodendrocyte maturation and myelin gene expression in PDGF-treated cultures from rat cerebral white matter. J Neurocytol 1993; 22: 322-33
25. Komoly S, Hudson LD, Webster H deF, Bondy CA. Insulin-like growth factor gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci USA 1992; 89: 1894-8
26. Kuratsu J-I, Sato K, Saitoh Y, Takeshima H, Morioka M, Ushio Y. The mechanism of growth-regulation of glioma cells by trapidil. J Neuro-Oncol 1995; 23: 201-6
27. Kuratsu J-I, Ushio Y. Antiproliferative effect of trapidil, a platelet-derived growth factor antagonist, on a glioma cell line in vitro. J Neurosurg 1990; 73: 436-40
28. Louis J-C, Magal E, Takayama S, Varon S. CNTF protection of oligodendrocytes against natural and tumour necrosis-induced death. Science 1993; 259: 689-92
29. Ludwin SK. Chronic demyelination inhibits remyelination in the central nervous system. Lab Invest 1980; 43: 382-7
30. Ludwin SK. Remyelination in the central nervous system and the peripheral nervous system. In Advances in Neurology, Vol. 47, Ed SG Waxman. New York: Raven Press, 1988: 215-54
31. Maresta A, Balducelli M, Cantini L et al. Trapidil (Triazolopyrimidine), a platelet-derived growth-factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty - results of the randomized, double-blind STARC study. Circulation 1994; 90: 2710-5
32. McKinnon R, Matsui T, Aaronson S, Dubois-Dalcq M. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 1990; 5: 603-14
33. McKinnon R, Piras G, Ida JA, Dubois-Dalcq M. A role for TGFβ- in oligodendrocyte differentiation. J Cell Biol 1993; 121: 1397-404
34. McMorris FA, Dubois-Dalcq M. Insulin-like growth factor 1 promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J Neurosci Res 1988; 21: 199-209
35. Mozell RL, McMorris FA. Insulin-like growth factor 1 stimulates oligodendrocyte development and myelination in rat brain aggregate cultures. J Neurosci Res 1991; 30: 382-90
36. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. PDGF promotes division and motility and inhibits premature differentiation of the oligodendrocyte-type-2 astrocyte progenitor cell. Nature 1988; 333: 560-5
37. Ohnishi H, Yamaguchi K, Shimada S. A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor. Life Sci 1981; 28: 1641-6
38. Peterson TC, Isbrucker RA, Hooper ML. In vitro effect of platelet-derived growth-factor on fibroproliferation and effect of cytokine antagonists. Immunopharmacology 1994; 28: 259-70
39. Pollack IF, Randall MS, Kristolik MP, Kelly RH, Selker RG, Vertosick FT. Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways. J Neurosurg 1991; 75: 284-93
40. Razzaque MS, Cheng M, Taguchi T. Trapidil modifies mesangial cell proliferation and collagen accumulation in anti-thymocyte serum (ATS)-induced glomerulonephritis. J Camp Pathol 1996; 114: 175-82
41. Reynolds R, Wilkin GP. Cellular reaction to an acute demyelinating/remyelinating lesion of the rat brain stem: localisation of GD3 ganglioside immunoreactivity. J Neurosci Res 1993; 36: 417-34
42. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 1988; 53: 309-19
43. Sakata N, Fujimitsu, Jimi S, Takebayashi S. PDGF-like growth-factor from SV40-transformed smooth-muscle cells promotes growth in an autocrine or paracrine manner. Exp Mol Pathol 1994; 60: 39-51
44. Scolding NJ, Compston DA. Growth factors fail to protect oligodendrocytes against humoral injury in vitro. Neurosci Lett 1995; 183: 75-8
45. Small RK, Riddle P, Noble M. Evidence for migration of oligodendrocyte-type-2 astrocyte progenitor cells into the developing rat optic nerve. Nature 1987; 328: 155-9
46. Todo T, Adams KF, Fahlbusch R. Inhibitory effect of trapidil on human meningioma cell proliferation via interruption of autocrine growth stimulation. J Neurosurg 1993; 78: 463-9
47. Tourbah A, Baron-Van Evercooren A, Oliver L, Raulais D, Jeanny JC, Gumpel M. Endogenous aFGF and cellular changes after a demyelinating lesion in the spinal cord of adult normal mice: immunohistochemical study. J Neurosci Res 1992; 33: 47-59
48. Yasuda T, Grinspan J, Stern J, Franceschini B, Bannerman P, Pleasure D. Apoptosis occurs in the oligodendroglial lineage, and is prevented by basic fibroblast growth factor. J Neurosci Res 1995; 40: 306-17
49. Yeh H-J, Ruit KG, Wang Y-X, Parks WC, Snider WD, Deuel TF. PDGF A-chain gene is expressed by mammalian neurons during development and in maturity. Cell 1991; 64: 209-16